Stay updated on Risankizumab Maintenance in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab Maintenance in Psoriasis Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe reference was updated from an ahead-of-print notice with a July 2025 date to the final September 2025 publication date, removing the online-ahead-of-print note.SummaryDifference0.2%
- Check22 days agoChange DetectedUpdated location name from Blankenfelde to Blankenfelde-Mahlow, Brandenburg, Germany, 15831, and upgraded software revision from v3.0.2 to v3.2.0.SummaryDifference0.2%
- Check37 days agoChange Detected- Updated version label from v3.0.1 to v3.0.2. - Removed the old revision tag (v3.0.1) and a Back to Top cue. - Overall impact appears to be a branding/version update with minimal to no change in core content or user-facing features.SummaryDifference0.1%
- Check44 days agoChange DetectedVersion updated from v3.0.0 to v3.0.1, and a Back to Top link was added; core content remains unchanged.SummaryDifference0.1%
- Check72 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check80 days agoChange DetectedThe web page has been updated from version 2.16.8 to version 2.16.11, indicating a revision in the content.SummaryDifference0.0%
Stay in the know with updates to Risankizumab Maintenance in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.